Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
RxSight, Inc.
| Metric | RxSight, Inc. RXSTHealthcare |
|---|---|
| Quality Score | 40 / 100 |
| Revenue (latest) | $134M |
| Net income (latest) | −$39M |
| Operating margin | −35.8% |
| Net margin | −29.0% |
| Return on equity | −14.1% |
| Return on assets | −12.5% |
| Return on capital (ROCE) | −16.9% |
| Debt / equity | 0.13× |
| Revenue growth (YoY) | −3.9% |
| Altman Z″ (distress) | 5.56 |
| Accruals / assets | −7.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.